Veeva (VEEV) Is Considered a Good Investment by Brokers: Is That True?
The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...
Zacks Investment Research on MSN3h
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the right ...
Veeva Shares Advance on Revenue, AI Growth
Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, VEEV has had strong sales and earnings growth: Also, EPS is estimated to ramp higher ...
Zacks Investment Research on MSN5d
Here's Why You Should Add Veeva Systems Stock to Your Portfolio Now
Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...
Fierce Biotech5d
Boehringer Ingelheim teams with Veeva to launch new R&D platform One Medicine
Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...
Veeva, Boehringer Ingelheim partner to launch ‘One Medicine Platform’
Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...
ANTARA News6d
Veeva CRM Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries
Veeva Systems (NYSE: VEEV) today announced Veeva CRM Pulse, a data subscription that provides quarterly healthcare ...